background
current
outbreak
threaten
health
care
system
sever
countri
around
world
control
measur
base
isol
quarantin
shown
decreas
delay
burden
ongo
epidem
respect
ongo
epidem
recent
model
work
show
intervent
techniqu
may
inadequ
control
local
outbreak
even
perfect
isol
assum
furthermor
effect
infecti
prior
symptom
onset
combin
signific
proport
asymptomat
infecte
complic
use
contact
trace
antivir
decreas
viral
load
reduc
infecti
could
integr
control
measur
order
augment
feasibl
control
epidem
method
use
simulationbas
model
viral
transmiss
test
efficaci
differ
intervent
measur
control
individu
identifi
contact
trace
evalu
two
procedur
monitor
individu
symptom
onset
test
individu
moreov
investig
effect
potent
antivir
compound
contact
trace
process
find
use
antivir
drug
combin
contact
trace
quarantin
isol
result
signific
decreas
final
size
peak
incid
increas
probabl
outbreak
fade
interpret
infecti
diseas
presymptomat
infect
plausibl
intervent
measur
base
contact
trace
perform
better
realiz
togeth
test
instead
monitor
provid
test
abl
detect
infect
incub
period
addit
test
scenario
model
highlight
benefit
administr
antivir
drug
addit
quarantin
isol
contact
trace
result
control
measur
could
effect
strategi
control
local
reemerg
outbreak
model
repres
viral
load
decreas
thereof
manuscript
first
present
effect
isol
consid
home
quarantin
individu
part
contact
trace
network
infect
individu
mild
symptom
hospit
isol
sever
case
argu
individu
quarantin
home
result
partial
reduct
contact
account
contact
household
member
isol
imperfect
compens
imperfect
isol
consid
use
antivir
compound
test
differ
control
measur
simul
studi
aim
repres
given
avail
inform
current
epidem
phase
epidem
mani
countri
alreadi
beyond
point
local
contain
howev
expect
methodolog
propos
key
avoid
second
peak
especi
given
limit
deplet
suscept
individu
initi
suscept
infect
enter
expos
class
e
notion
infecti
contact
process
first
contact
individu
gener
contact
gener
suscept
infecti
peopl
result
infect
event
accord
bernoulli
probabl
valu
base
time
sinc
infect
probabl
comput
precis
time
point
product
two
compon
infecti
measur
quantifi
level
infecti
time
total
amount
infect
q
ie
number
infect
contact
rate
function
defin
expos
infecti
period
analog
incub
symptomat
period
along
integr
one
function
scale
similar
shape
among
differ
infect
base
length
expos
infecti
period
accord
framework
infecti
individu
make
effect
contact
rate
r
given
contact
rate
mean
number
effect
contact
approxim
reproduct
number
two
quantiti
ident
infinit
homogen
popul
probabl
make
two
effect
contact
person
zero
consid
popul
size
probabl
event
extrem
low
therefor
throughout
manuscript
approxim
reproduct
number
mean
number
secondari
case
consid
framework
isolationquarantin
implement
reduc
contact
rate
time
diagnosi
date
littl
known
differ
viral
load
among
sever
mild
case
zhou
et
al
indic
nasal
throat
swab
viral
load
higher
mild
case
due
uncertainti
assum
curv
defin
infect
individu
work
assum
popul
homogen
close
finit
popul
assumpt
relat
control
measur
current
place
eg
itali
aim
contain
immigr
emigr
countri
ongo
outbreak
tabl
report
paramet
distribut
util
simul
studi
distribut
report
paramet
assum
constant
last
column
avail
report
refer
literatur
justifi
choic
paramet
valu
distribut
use
assum
infecti
individu
make
averag
two
three
effect
contact
nasal
throat
swab
data
time
hospit
estim
data
present
backer
et
al
assum
time
hospit
coincid
time
diagnosi
contact
trace
procedur
start
assum
contact
h
trace
back
success
probabl
depend
consid
scenario
tracedback
individu
monitor
test
individu
found
posit
put
quarantineisol
certain
scenario
next
quarantin
also
inject
infect
individu
antivir
drug
ie
remdesivir
assum
test
detect
infect
two
day
sinc
infect
trace
individu
test
neg
first
time
test
two
day
quarantin
result
decreas
contact
rate
ie
imperfect
isol
q
case
perfect
isol
contact
rate
set
zero
similarli
diagnos
individu
also
quarantin
home
mild
symptom
decreas
contact
rate
q
hospit
sever
symptom
assum
perfect
compens
imperfect
isol
investig
use
antivir
compound
reduc
infecti
infect
individu
assum
antivir
compound
administ
infecti
measur
exponenti
decay
accord
invers
malthusian
growth
model
shown
figur
rate
decay
set
repres
reduct
viral
load
due
remdesevir
report
mer
coronaviru
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
figur
reduct
infecti
blue
orang
line
describ
infecti
measur
respect
dash
blue
antivir
inject
solid
yellow
red
arrow
indic
inject
time
assum
follow
paramet
reduct
contact
home
quarantin
q
probabl
trace
back
contact
histori
h
scenario
consid
scenario
assum
individu
isol
quarantin
diagnos
moreov
assum
contact
trace
start
time
diagnosi
ia
trace
individu
monitor
two
week
isolatedquarantin
show
symptom
period
scenario
similar
baselin
scenario
describ
hellewel
et
al
except
descript
sever
case
isol
mild
home
quarantin
scenario
reflect
realist
current
practic
contain
ib
trace
individu
isolatedquarantin
soon
test
posit
assum
individu
infect
test
posit
day
infect
therefor
trace
individu
test
immedi
trace
test
neg
test
individu
two
day
later
ibtb
diagnos
patient
immedi
treat
antivir
drug
furthermor
trace
individu
isolatedquarantin
inject
antivir
drug
soon
test
posit
assum
individu
infect
test
posit
day
infect
therefor
trace
individu
test
immedi
trace
test
neg
test
individu
two
day
later
scenario
run
simul
among
comput
final
size
case
peak
one
least
individu
infect
account
outbreak
challeng
contain
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
success
trace
contact
reduct
contact
rate
due
quarantin
figur
isol
quarantin
lead
substanti
decreas
final
size
peak
incid
perform
prior
symptom
onset
efficaci
increas
import
recent
work
indic
infecte
infecti
prior
symptom
onset
antivir
treatment
shown
scenario
ia
yellow
scenario
ib
green
scenario
ibtb
blue
quarantin
contact
rate
q
togeth
probabl
simul
lead
number
case
smaller
popul
purpl
asterisk
right
panel
mean
peak
incid
togeth
percentil
substanti
impact
togeth
quarantin
isol
significantli
reduc
final
size
peak
incid
number
outbreak
challeng
contain
assum
suffici
antivir
drug
dose
treat
individu
encount
via
contact
trace
procedur
motiv
fact
consid
emerg
outbreak
requir
number
dose
thu
limit
furthermor
assum
individu
show
symptom
sooner
later
infecti
period
therefor
infect
individu
diagnos
due
awar
show
test
scenario
use
antivir
drug
increas
control
outbreak
even
undiagnos
individu
circul
popul
hospit
assum
perfect
isol
mean
infect
individu
spread
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
ongo
epidem
threaten
health
system
mani
countri
although
consid
set
reproduct
number
symptomat
asymptomat
equal
figur
set
asymptomat
infecte
reproduct
number
reproduct
number
set
symptomat
infecte
figur
set
show
signific
advantag
respect
reduct
final
size
peak
incid
yet
analysi
also
show
asymptomat
infecti
symptomat
infecte
import
high
contact
trace
success
rate
remain
hope
ongo
clinic
trial
reveal
antivir
compound
report
figur
sensit
analysi
quarantin
contact
rate
q
introduct
antivir
compound
substanti
contribut
reduc
final
size
peak
incid
probabl
challeng
outbreak
consid
set
decreas
compar
scenario
isolationquarantin
implement
increas
quarantin
less
effect
left
panel
figur
vari
reproduct
number
set
respect
r
r
effect
antivir
drug
addit
isol
quarantin
increas
reproduct
number
increas
case
r
case
remark
impact
final
size
peak
incid
test
also
effect
asymptomat
proport
infect
assum
authorfund
grant
medrxiv
licens
display
preprint
perpetu
figur
mean
peak
incid
scenario
ia
yellow
scenario
ib
green
scenario
ibtb
blue
quarantin
contact
rate
q
left
panel
q
right
panel
togeth
percentil
figur
final
size
distribut
left
panel
mean
peak
incid
scenario
ia
yellow
scenario
ib
green
scenario
ibtb
blue
quarantin
contact
rate
q
r
left
panel
scenario
report
probabl
simul
lead
number
case
smaller
popul
purpl
asterisk
right
panel
togeth
point
estim
report
percentil
figur
final
size
distribut
left
panel
mean
peak
incid
scenario
ia
yellow
scenario
ib
green
scenario
ibtb
blue
quarantin
contact
rate
q
r
left
panel
scenario
report
probabl
simul
lead
number
case
smaller
popul
purpl
asterisk
right
panel
togeth
point
estim
report
percentil
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
figur
final
size
distribut
left
panel
mean
peak
incid
scenario
ia
yellow
scenario
ib
green
scenario
ibtb
blue
quarantin
contact
rate
q
r
test
detect
posit
infecti
individu
day
sinc
infect
left
panel
scenario
report
probabl
simul
lead
number
case
smaller
popul
purpl
asterisk
right
panel
togeth
point
estim
report
percentil
number
valu
r
figur
reproduct
number
symptomat
asymptomat
set
respect
r
r
r
also
scenario
notic
administr
antivir
drug
lead
substanti
decreas
final
size
peak
incid
compar
valu
obtain
control
measur
consid
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
figur
final
size
distribut
left
panel
mean
peak
incid
scenario
ia
yellow
scenario
ib
green
scenario
ibtb
blue
quarantin
contact
rate
q
proport
asymptomat
individu
consid
reproduct
number
asymptomat
r
symptomat
r
individu
r
r
left
panel
scenario
report
probabl
simul
lead
number
case
smaller
popul
purpl
asterisk
right
panel
togeth
point
estim
report
percentil
figur
final
size
distribut
left
panel
mean
peak
incid
scenario
ia
yellow
scenario
ib
green
scenario
ibtb
blue
quarantin
contact
rate
q
r
proport
asymptomat
individu
consid
reproduct
number
differ
asymptomat
r
symptomat
r
individu
r
r
r
left
panel
scenario
report
probabl
simul
lead
number
case
smaller
popul
purpl
asterisk
right
panel
togeth
point
estim
report
percentil
